Stockreport

Alnylam Announces Unaudited Fourth Quarter 2018 Global Revenues for ONPATTRO® (patisiran) and Provides Additional Commercial Updates

Alnylam Pharmaceuticals, Inc.  (ALNY) 
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.alnylam.com/investor-overview
PDF - Achieved Fourth Quarter 2018 ONPATTRO Unaudited Global Net Product Revenues of $11-12 Million – - Over 200 Patients on Commercial ONPATTRO in U [Read more]